Your browser doesn't support javascript.
COVID-19 Vaccination Perceptions in Patients With Rheumatic Disease: A Cross-Sectional Online Survey.
Butt, Imama N; van Eeden, Charmaine; Burns, Katharina Kovacs; Saxinger, Lynora; Clifford, Alison; Tervaert, Jan W Cohen; Yacyshyn, Elaine A.
  • Butt IN; I.N. Butt, BSc, University of Alberta.
  • van Eeden C; C. van Eeden, PhD, L. Saxinger, MD, A. Clifford, MD, J.W. Cohen Tervaert, MD, PhD, E.A. Yacyshyn, MD, Department of Medicine, University of Alberta.
  • Burns KK; K. Kovacs Burns, PhD, School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
  • Saxinger L; C. van Eeden, PhD, L. Saxinger, MD, A. Clifford, MD, J.W. Cohen Tervaert, MD, PhD, E.A. Yacyshyn, MD, Department of Medicine, University of Alberta.
  • Clifford A; C. van Eeden, PhD, L. Saxinger, MD, A. Clifford, MD, J.W. Cohen Tervaert, MD, PhD, E.A. Yacyshyn, MD, Department of Medicine, University of Alberta.
  • Tervaert JWC; C. van Eeden, PhD, L. Saxinger, MD, A. Clifford, MD, J.W. Cohen Tervaert, MD, PhD, E.A. Yacyshyn, MD, Department of Medicine, University of Alberta.
  • Yacyshyn EA; C. van Eeden, PhD, L. Saxinger, MD, A. Clifford, MD, J.W. Cohen Tervaert, MD, PhD, E.A. Yacyshyn, MD, Department of Medicine, University of Alberta; eyacyshyn@ualberta.ca.
J Rheumatol ; 50(5): 690-696, 2023 05.
Article in English | MEDLINE | ID: covidwho-2313307
ABSTRACT

OBJECTIVE:

To identify the factors that affect coronavirus disease 2019 (COVID-19) vaccine decision making among individuals diagnosed with a rheumatologic condition, given that previous international studies have demonstrated that a significant proportion of patients with rheumatic disease (RD) are vaccine hesitant.

METHODS:

This cross-sectional study involved an online survey with adult patients with RD from the Kaye Edmonton Clinic Rheumatology Clinic between June and August 2021. Quantitative results were descriptively analyzed, whereas qualitative thematic analysis was conducted for open-ended responses.

RESULTS:

The survey had a response rate of 70.9% (N = 231). Regarding COVID-19 vaccines, patients with RD were most concerned about the possible effect of vaccination on their rheumatic condition (45.2%) and about vaccine effectiveness (45.1%). Most patients had discussed COVID-19 vaccination (75.9%) and its risks and benefits (66.1%) with their medical team, and 83.6% of respondents were confident in the information provided. Patients' perceptions of the government's role in handling the COVID-19 pandemic varied 33% reported that they found government-instituted public health measures effective. Surprisingly, 9.7% of patients with RD still reported concerns that they could develop COVID-19 from an approved COVID-19 vaccine.

CONCLUSION:

This study describes factors implicated in COVID-19 vaccine decision making among patients with RD. Three important themes included possible adverse effects of the vaccine on RD control, reduced vaccine efficacy because of RD/treatment, and risk of contracting SARS-CoV-2 from the COVID-19 vaccine. Knowledge from this study can assist healthcare providers in looking after patients with RD to initiate discussions with patients to share evidence-based vaccine information and assist with informed decision making.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rheumatic Diseases / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Vaccines Limits: Adult / Humans Language: English Journal: J Rheumatol Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Rheumatic Diseases / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Vaccines Limits: Adult / Humans Language: English Journal: J Rheumatol Year: 2023 Document Type: Article